ATA21096A - Neue formen von paroxetin-hydrochlorid-anhydrat - Google Patents

Neue formen von paroxetin-hydrochlorid-anhydrat

Info

Publication number: ATA21096A
Authority: AT; Austria
Prior art keywords: new forms; paroxetine hydrochloride; hydrochloride anhydrate; anhydrate; paroxetine
Prior art date: 1995-02-06

Application number

AT0021096A

Other languages

English (en)

Other versions

AT407528B (de

Original Assignee

Smithkline Beecham Plc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1995-02-06

Filing date

1996-02-05

Publication date

2000-08-15

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27267578&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATA21096(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

1995-02-06 Priority claimed from GBGB9502297.6A external-priority patent/GB9502297D0/en

1995-02-17 Priority claimed from GBGB9503112.6A external-priority patent/GB9503112D0/en

1995-05-15 Priority claimed from GBGB9509807.5A external-priority patent/GB9509807D0/en

1996-02-05 Application filed by Smithkline Beecham Plc filed Critical Smithkline Beecham Plc

2000-08-15 Publication of ATA21096A publication Critical patent/ATA21096A/de

2001-04-25 Application granted granted Critical

2001-04-25 Publication of AT407528B publication Critical patent/AT407528B/de

Links

AHOUBRCZNHFOSL-UHFFFAOYSA-N 3-(1,3-benzodioxol-5-yloxymethyl)-4-(4-fluorophenyl)piperidine Chemical compound C1=CC(F)=CC=C1C1C(COC=2C=C3OCOC3=CC=2)CNCC1 AHOUBRCZNHFOSL-UHFFFAOYSA-N 0.000 title 2
229960005183 paroxetine hydrochloride Drugs 0.000 title 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/26—Psychostimulants, e.g. nicotine, cocaine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents

Landscapes

Health & Medical Sciences (AREA)
Organic Chemistry (AREA)
Chemical & Material Sciences (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Bioinformatics & Cheminformatics (AREA)
General Health & Medical Sciences (AREA)
General Chemical & Material Sciences (AREA)
Veterinary Medicine (AREA)
Engineering & Computer Science (AREA)
Neurosurgery (AREA)
Biomedical Technology (AREA)
Neurology (AREA)
Psychiatry (AREA)
Pain & Pain Management (AREA)
Diabetes (AREA)
Hematology (AREA)
Obesity (AREA)
Child & Adolescent Psychology (AREA)
Hospice & Palliative Care (AREA)
Toxicology (AREA)
Plural Heterocyclic Compounds (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

AT0021096A 1995-02-06 1996-02-05 Neue formen von paroxetin-hydrochlorid-anhydrat AT407528B (de)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
GBGB9502297.6A GB9502297D0 (en)	1995-02-06	1995-02-06	Novel compound
GBGB9503112.6A GB9503112D0 (en)	1995-02-17	1995-02-17	Novel compound
GBGB9509807.5A GB9509807D0 (en)	1995-05-15	1995-05-15	Novel compounds

Publications (2)

Publication Number	Publication Date
ATA21096A true ATA21096A (de)	2000-08-15
AT407528B AT407528B (de)	2001-04-25

Family

ID=27267578

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT0021096A AT407528B (de)	1995-02-06	1996-02-05	Neue formen von paroxetin-hydrochlorid-anhydrat

Country Status (47)

Country	Link
EP (3)	EP1378508A1 (de)
JP (2)	JP2915338B2 (de)
KR (1)	KR100289885B1 (de)
CN (3)	CN1090187C (de)
AR (2)	AR001982A1 (de)
AT (1)	AT407528B (de)
AU (2)	AU701518C (de)
BE (1)	BE1009112A3 (de)
BG (1)	BG62967B1 (de)
BR (1)	BR9600534A (de)
CA (2)	CA2211522C (de)
CH (3)	CH689804A5 (de)
CZ (1)	CZ297171B6 (de)
DE (3)	DE69621777T2 (de)
DK (2)	DK11996A (de)
DZ (1)	DZ1989A1 (de)
ES (1)	ES2114471B1 (de)
FI (3)	FI111544B (de)
FR (1)	FR2730232B1 (de)
GR (1)	GR1002466B (de)
HK (1)	HK59397A (de)
HU (1)	HUP9600255A1 (de)
IE (1)	IE80500B1 (de)
IL (1)	IL117035A (de)
IT (1)	IT1289532B1 (de)
LU (1)	LU88711A1 (de)
LV (1)	LV11618B (de)
MA (1)	MA23802A1 (de)
MC (1)	MC2411A1 (de)
MX (1)	MX9600484A (de)
MY (1)	MY132529A (de)
NL (1)	NL1002248C2 (de)
NO (3)	NO301009B1 (de)
NZ (1)	NZ280943A (de)
OA (1)	OA10261A (de)
PL (1)	PL189247B1 (de)
PT (1)	PT101827B (de)
RO (1)	RO112426B1 (de)
RU (1)	RU2125052C1 (de)
SE (1)	SE521084C2 (de)
SG (1)	SG43787A1 (de)
SI (2)	SI21923B (de)
SK (1)	SK283608B6 (de)
TR (1)	TR199600096A2 (de)
TW (1)	TW503238B (de)
UA (1)	UA49796C2 (de)
WO (1)	WO1996024595A1 (de)

Families Citing this family (39)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JP3882224B2 (ja)	1996-05-31	2007-02-14	旭硝子株式会社	パロキセチンの製造方法
EP1394160A1 (de) *	1996-06-13	2004-03-03	SUMIKA FINE CHEMICALS Co., Ltd.	Verfahren zur Herstellung von kristallinem Paroxetin-Hydrochlorid
WO1998002556A2 (en) *	1996-07-15	1998-01-22	Smithkline Beecham Plc	Screening for and use of an esterase for a stereospecific resolution
US5672612A (en) *	1996-09-09	1997-09-30	Pentech Pharmaceuticals, Inc.	Amorphous paroxetine composition
US6638948B1 (en)	1996-09-09	2003-10-28	Pentech Pharmaceuticals, Inc.	Amorphous paroxetine composition
SK283394B6 (sk)	1997-06-10	2003-07-01	Synthon B. V.	Zlúčeniny 4-fenylpiperidínu a jej farmaceuticky prijateľné soli, spôsob ich prípravy, liečivo s ich obsahom a ich použitie
EP0903345B1 (de) *	1997-08-08	2000-10-04	Aventis Pharma Deutschland GmbH	Kristallform von 5-Methylisoxazol-4-carbonsäure-(4-trifluormethyl)-anilid
GB9726907D0 (en) *	1997-12-19	1998-02-18	Smithkline Beecham Plc	Novel compounds
HUP0101215A3 (en) *	1998-03-16	2002-05-28	Smithkline Beecham Plc	Chrystalline form of paroxetine
GB9806312D0 (en) *	1998-03-24	1998-05-20	Smithkline Beecham Plc	Novel formulations
AU2003200534B2 (en) *	1998-03-24	2004-12-02	Smithkline Beecham Plc	Paroxetine compositions
US6699882B2 (en)	1998-03-24	2004-03-02	Smithkline Beecham P.L.C.	Paroxetine compositions
JP3796351B2 (ja) *	1998-04-13	2006-07-12	住友化学株式会社	パロキセチン塩酸塩無水和物の乾燥方法
GB9812941D0 (en) *	1998-06-16	1998-08-12	Smithkline Beecham Plc	Method of treatment
CH689805A8 (fr) *	1998-07-02	2000-02-29	Smithkline Beecham Plc	Méthanesulfonate de paroxétine, procédé pour sa préparation et compositions pharmaceutiques le contenant.
ES2138937B1 (es)	1998-07-07	2000-10-01	Medichem Sa	Polimorfo de maleato de paroxetina y formulaciones farmaceuticas que lo contienen.
CA2339857A1 (en) *	1998-08-07	2000-02-17	Neal Ward	Process for the preparation of a non-crystalline anhydrate form of paroxetine hydrochloride
GB9824298D0 (en) *	1998-11-05	1998-12-30	Smithkline Beecham Plc	Novel process
GB9826175D0 (en) *	1998-11-28	1999-01-20	Smithkline Beecham Plc	Novel process
GB9826176D0 (en) *	1998-11-28	1999-01-20	Smithkline Beecham Plc	Novel process
GB9826180D0 (en) *	1998-11-30	1999-01-20	Smithkline Beecham Plc	Novel process
GB9826178D0 (en) *	1998-11-30	1999-01-20	Smithkline Beecham Plc	Novel process
GB9826242D0 (en) *	1998-11-30	1999-01-20	Smithkline Beecham Plc	Novel process
GB9826171D0 (en) *	1998-11-30	1999-01-20	Smithkline Beecham Plc	Novel compounds
EP1408039A3 (de) *	1998-11-30	2004-05-12	Smithkline Beecham Plc	Gemischte paroxetin-propan-2-olsolvate
GB9828767D0 (en) *	1998-12-29	1999-02-17	Smithkline Beecham Plc	Novel process
IT1308629B1 (it) *	1999-02-23	2002-01-09	Recordati Chem Pharm	Processo per la produzione di paroxetina.
JP4854115B2 (ja) *	1999-03-12	2012-01-18	エイシカファーマシューティカルスリミテッド	無水パロキセチン用安定製剤形
GB9914585D0 (en) *	1999-06-22	1999-08-25	Smithkline Beecham Plc	Novel process
GB9914583D0 (en) *	1999-06-22	1999-08-25	Smithkline Beecham Plc	Novel process
SE9902550D0 (sv) *	1999-07-02	1999-07-02	Astra Ab	New crystalline forms
GB9919001D0 (en) *	1999-08-12	1999-10-13	Smithkline Beecham Plc	Novel process
GB9923445D0 (en) *	1999-10-04	1999-12-08	Smithkline Beecham Plc	Novel process
GB9923446D0 (en) *	1999-10-04	1999-12-08	Smithkline Beecham Plc	Novel process
GB9923439D0 (en) *	1999-10-04	1999-12-08	Smithkline Beecham Plc	Novel process
HU226912B1 (en) *	2000-04-07	2010-03-01	Richter Gedeon Nyrt	New paroxetin salt and medicament containing it
WO2002022609A1 (en) *	2000-09-14	2002-03-21	Asahi Glass Company, Limited	Process for producing paroxetine salt containing substantially no organic solvent
WO2003072104A1 (en) *	2002-02-22	2003-09-04	Teva Pharmaceutical Industries Ltd.	Preparation of paroxetine involving novel intermediates
EP1828098A1 (de) *	2005-11-22	2007-09-05	Teva Pharmaceutical Industries Ltd	Kristallformen von cinacalcet hci und verfahren zu ihrer herstellung

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB1422263A (en) *	1973-01-30	1976-01-21	Ferrosan As	4-phenyl-piperidine compounds
GB8430581D0 (en) *	1984-12-04	1985-01-09	Ferrosan As	Treatment
EP0223403B1 (de) *	1985-10-25	1993-08-04	Beecham Group Plc	Piperidinderivat, seine Herstellung und seine Verwendung als Arzneimittel
US5017585A (en) *	1986-11-03	1991-05-21	Novo Nordisk A/S	Method of treating calcium overload
GB8626936D0 (en) *	1986-11-11	1986-12-10	Ferrosan As	Treatment
DK715988D0 (da) *	1988-12-22	1988-12-22	Ferrosan As	Etherifikation og dealkylering af piperidin-derivater samt intermediater
DK716088D0 (da) *	1988-12-22	1988-12-22	Ferrosan As	Reduktion af piperidin-dion-derivater samt intermediat
AU658155B2 (en) *	1990-11-24	1995-04-06	Beecham Group Plc	Use of paroxetine for the treatment of senile dementia, or anorexia
US5258517A (en) *	1992-08-06	1993-11-02	Sepracor, Inc.	Method of preparing optically pure precursors of paroxetine
GB9325644D0 (en) *	1993-12-15	1994-02-16	Smithkline Beecham Plc	Novel formulation

1996
- 1996-02-01 AR ARP960101230A patent/AR001982A1/es not_active Application Discontinuation
- 1996-02-01 SK SK143-96A patent/SK283608B6/sk not_active IP Right Cessation
- 1996-02-02 IE IE960104A patent/IE80500B1/en not_active IP Right Cessation
- 1996-02-02 WO PCT/EP1996/000447 patent/WO1996024595A1/en not_active Ceased
- 1996-02-02 CZ CZ0032096A patent/CZ297171B6/cs not_active IP Right Cessation
- 1996-02-02 EP EP03078024A patent/EP1378508A1/de not_active Withdrawn
- 1996-02-02 AU AU43328/96A patent/AU701518C/en not_active Ceased
- 1996-02-02 BR BR9600534A patent/BR9600534A/pt not_active IP Right Cessation
- 1996-02-02 DE DE69621777T patent/DE69621777T2/de not_active Expired - Lifetime
- 1996-02-02 EP EP96903970A patent/EP0808314B1/de not_active Expired - Lifetime
- 1996-02-02 LV LVP-96-31A patent/LV11618B/en unknown
- 1996-02-02 MX MX9600484A patent/MX9600484A/es not_active IP Right Cessation
- 1996-02-02 DE DE1996631298 patent/DE69631298T2/de not_active Expired - Lifetime
- 1996-02-02 MC MC2329A patent/MC2411A1/fr unknown
- 1996-02-02 FR FR9601297A patent/FR2730232B1/fr not_active Expired - Fee Related
- 1996-02-02 MY MYPI96000383A patent/MY132529A/en unknown
- 1996-02-02 RO RO96-00183A patent/RO112426B1/ro unknown
- 1996-02-02 DE DE19603797A patent/DE19603797C2/de not_active Revoked
- 1996-02-02 EP EP01115079A patent/EP1136490B1/de not_active Expired - Lifetime
- 1996-02-02 AU AU47864/96A patent/AU4786496A/en not_active Abandoned
- 1996-02-03 SG SG1996000861A patent/SG43787A1/en unknown
- 1996-02-03 KR KR1019960002620A patent/KR100289885B1/ko not_active Expired - Fee Related
- 1996-02-04 DZ DZ960030A patent/DZ1989A1/fr active
- 1996-02-05 CN CN96103526A patent/CN1090187C/zh not_active Expired - Fee Related
- 1996-02-05 NL NL1002248A patent/NL1002248C2/xx not_active IP Right Cessation
- 1996-02-05 SI SI9600378A patent/SI21923B/sl not_active IP Right Cessation
- 1996-02-05 IL IL11703596A patent/IL117035A/xx unknown
- 1996-02-05 TW TW085101374A patent/TW503238B/zh not_active IP Right Cessation
- 1996-02-05 MA MA24157A patent/MA23802A1/fr unknown
- 1996-02-05 GR GR960100038A patent/GR1002466B/el not_active IP Right Cessation
- 1996-02-05 ES ES09600262A patent/ES2114471B1/es not_active Expired - Fee Related
- 1996-02-05 CN CNB2004100855519A patent/CN1289496C/zh not_active Expired - Fee Related
- 1996-02-05 BE BE9600101A patent/BE1009112A3/fr not_active IP Right Cessation
- 1996-02-05 JP JP8018679A patent/JP2915338B2/ja not_active Expired - Fee Related
- 1996-02-05 HU HU9600255A patent/HUP9600255A1/hu unknown
- 1996-02-05 NO NO960472A patent/NO301009B1/no not_active IP Right Cessation
- 1996-02-05 AT AT0021096A patent/AT407528B/de not_active IP Right Cessation
- 1996-02-05 PL PL96312646A patent/PL189247B1/pl unknown
- 1996-02-05 SE SE9600406A patent/SE521084C2/sv not_active IP Right Cessation
- 1996-02-05 IT IT96MI000203A patent/IT1289532B1/it active IP Right Grant
- 1996-02-05 SI SI9600036A patent/SI9600036B/sl not_active IP Right Cessation
- 1996-02-05 UA UA96020442A patent/UA49796C2/uk unknown
- 1996-02-05 CA CA002211522A patent/CA2211522C/en not_active Expired - Fee Related
- 1996-02-05 NZ NZ280943A patent/NZ280943A/en not_active IP Right Cessation
- 1996-02-05 RU RU96102180A patent/RU2125052C1/ru not_active IP Right Cessation
- 1996-02-05 BG BG100333A patent/BG62967B1/bg unknown
- 1996-02-05 LU LU88711A patent/LU88711A1/fr unknown
- 1996-02-05 DK DK011996A patent/DK11996A/da not_active Application Discontinuation
- 1996-02-05 CA CA002210022A patent/CA2210022C/en not_active Expired - Fee Related
- 1996-02-05 FI FI960519A patent/FI111544B/fi not_active IP Right Cessation
- 1996-02-06 CH CH02051/98A patent/CH689804A5/de not_active IP Right Cessation
- 1996-02-06 CH CH01510/97A patent/CH689229A5/de not_active IP Right Cessation
- 1996-02-06 CH CH00304/96A patent/CH688353A5/de not_active IP Right Cessation
- 1996-02-06 TR TR96/00096A patent/TR199600096A2/xx unknown
- 1996-02-06 PT PT101827A patent/PT101827B/pt not_active IP Right Cessation
- 1996-02-06 OA OA60773A patent/OA10261A/en unknown
1997
- 1997-02-28 NO NO19970939A patent/NO311519B1/no not_active IP Right Cessation
- 1997-05-08 HK HK59397A patent/HK59397A/xx not_active IP Right Cessation
1998
- 1998-12-02 JP JP10342812A patent/JPH11228571A/ja active Pending
2000
- 2000-08-31 CN CN001268872A patent/CN1216055C/zh not_active Expired - Fee Related
2001
- 2001-02-12 DK DKPA200100223 patent/DK200100223A/da not_active Application Discontinuation
- 2001-10-18 NO NO20015070A patent/NO20015070D0/no not_active Application Discontinuation
2002
- 2002-10-18 AR ARP020103931A patent/AR036856A2/es unknown
2003
- 2003-02-03 FI FI20030162A patent/FI20030162A7/fi unknown
- 2003-03-12 FI FI20030370A patent/FI20030370L/fi not_active Application Discontinuation

Also Published As

Publication number	Publication date
MX9600484A (es)	1997-01-31
KR100289885B1 (ko)	2001-05-15
CA2210023C (en)	1999-02-09
LU88711A1 (fr)	1996-08-23
CN1636993A (zh)	2005-07-13
EP1378508A1 (de)	2004-01-07
SI21923A (sl)	2006-06-30
CH689804A5 (de)	1999-11-30
TR199600096A2 (tr)	1996-08-21
MC2411A1 (fr)	1996-12-02
DE69621777D1 (de)	2002-07-18
FR2730232B1 (fr)	1997-08-01
OA10261A (en)	1997-09-19
IE960104A1 (en)	1996-08-07
CA2168829A1 (en)	1996-08-07
CA2211522A1 (en)	1996-08-07
LV11618A (lv)	1996-12-20
HUP9600255A1 (en)	1997-03-28
FI960519A0 (fi)	1996-02-05
EP1136490A1 (de)	2001-09-26
CN1216055C (zh)	2005-08-24
NO20015070L (no)	1996-08-07
DE69631298D1 (de)	2004-02-12
KR960031409A (ko)	1996-09-17
CN1143643A (zh)	1997-02-26
DK200100223A (de)	2001-02-12
HU9600255D0 (en)	1996-03-28
CA2168829C (en)	1997-12-16
DE69631298T2 (de)	2004-11-18
ITMI960203A0 (de)	1996-02-05
ITMI960203A1 (it)	1997-08-05
RU2125052C1 (ru)	1999-01-20
JPH11228571A (ja)	1999-08-24
EP1136490B1 (de)	2004-01-07
NL1002248A1 (nl)	1996-08-06
LV11618B (en)	1997-04-20
RO112426B1 (ro)	1997-09-30
GR1002466B (el)	1996-11-06
JP2915338B2 (ja)	1999-07-05
SI21923B (sl)	2006-12-31
NO970939D0 (no)	1997-02-28
FI20030162L (fi)	2003-02-03
HK59397A (en)	1997-05-16
CZ297171B6 (cs)	2006-09-13
IT1289532B1 (it)	1998-10-15
IE80500B1 (en)	1998-08-12
FI111544B (fi)	2003-08-15
SE9600406D0 (sv)	1996-02-05
AT407528B (de)	2001-04-25
AU4332896A (en)	1996-08-15
NZ280943A (en)	1997-01-29
BG62967B1 (bg)	2000-12-29
NO960472D0 (no)	1996-02-05
ES2114471B1 (es)	1999-08-16
FI20030162A7 (fi)	2003-02-03
PL189247B1 (pl)	2005-07-29
IL117035A (en)	2000-02-29
CH689229A5 (de)	1998-12-31
CA2211522C (en)	1999-12-07
SG43787A1 (en)	1997-11-14
WO1996024595A1 (en)	1996-08-15
DE19603797A1 (de)	1996-08-14
EP0808314B1 (de)	2002-06-12
ES2114471A1 (es)	1998-05-16
EP0808314A1 (de)	1997-11-26
BG100333A (bg)	1996-08-30
CA2210022C (en)	2005-09-13
BE1009112A3 (fr)	1996-11-05
NO301009B1 (no)	1997-09-01
CN1289496C (zh)	2006-12-13
NL1002248C2 (nl)	1996-09-11
CA2210023A1 (en)	1996-08-07
TW503238B (en)	2002-09-21
PT101827B (pt)	1997-08-29
SI9600036B (sl)	2006-12-31
NO301009B3 (de)	2003-01-06
IL117035A0 (en)	1996-09-12
CH688353A5 (de)	1997-08-15
SE521084C2 (sv)	2003-09-30
UA49796C2 (uk)	2002-10-15
FI20030370A7 (fi)	2003-03-12
DE19603797C2 (de)	1998-11-12
NO311519B1 (no)	2001-12-03
FR2730232A1 (fr)	1996-08-09
NO20015070D0 (no)	2001-10-18
CN1310180A (zh)	2001-08-29
SK14396A3 (en)	1996-11-06
CN1090187C (zh)	2002-09-04
DK11996A (da)	1996-08-07
DZ1989A1 (fr)	2002-10-15
SI9600036A (en)	1996-10-31
PL312646A1 (en)	1996-08-19
MY132529A (en)	2007-10-31
FI20030370L (fi)	2003-03-12
MX198371B (de)	2000-08-29
NO960472L (no)	1996-08-07
SK283608B6 (sk)	2003-10-07
CA2210022A1 (en)	1996-08-07
DE69621777T2 (de)	2003-01-02
AU701518C (en)	2006-12-07
AR036856A2 (es)	2004-10-06
AU4786496A (en)	1996-08-27
AU701518B2 (en)	1999-01-28
JPH08245620A (ja)	1996-09-24
NO970939L (no)	1996-08-07
AR001982A1 (es)	1998-01-07
SE9600406L (sv)	1996-08-07
CZ32096A3 (en)	1996-08-14
PT101827A (pt)	1996-09-30
BR9600534A (pt)	1997-05-13
MA23802A1 (fr)	1996-10-01
FI960519L (fi)	1996-08-07

Legal Events

Date	Code	Title	Description
1996-11-15	REN	Ceased due to non-payment of the annual fee
2014-04-15	MM01	Lapse because of not paying annual fees	Effective date: 20130815

Publication	Publication Date	Title
ATA21096A (de)	2000-08-15	Neue formen von paroxetin-hydrochlorid-anhydrat
DE19681286T1 (de)	1998-04-02	Neue Kristallform von Olanzapin
DE69631390D1 (de)	2004-02-26	Substituierte Benzylaminpiperidin-Verbindungen
DE69621495D1 (de)	2002-07-11	Formen von Schokoladen
DE69635284D1 (de)	2006-02-23	Neue substituierte napthopyrane
DE69704469D1 (de)	2001-05-10	Hertellungsverfahren von Acrylnitril-modifizierten Tonerzusammensetzungen
DE69604996D1 (de)	1999-12-09	Halbbrückentreiberschaltung
EP0791009A4 (de)	2003-03-05	Modifizierter neuropeptid-y-rezeptor
ATE231521T1 (de)	2003-02-15	Kristalline formen von eto2c-ch2-(r)cgl-aze-pab- oh
FI960516L (fi)	1996-08-07	Substituoituja bifenyylisulfonamidiendoteliiniantagonisteja
EP0833628A4 (de)	2002-05-02	Neue taxoide
DE69627954D1 (de)	2003-06-12	Herstellungsverfahren von Luftbrücker
DE69522582D1 (de)	2001-10-11	NEUE VERWENDUNGEN VON INDOLO-[2,3b]-CHINOXALINEN
DE69607261D1 (de)	2000-04-27	Anschlussbrücke
DE69627732D1 (de)	2003-06-05	Modifizierte Zusammensetzung von Asphaltzement
ATE293113T1 (de)	2005-04-15	Neue polymorphe formen von olanzapin
DE69706564D1 (de)	2001-10-11	Neue carboxy-substituierte cyclische carboxamidderivate
DE69520374D1 (de)	2001-04-19	Formen von Strukturelementen
ATE202556T1 (de)	2001-07-15	Neue formen der organischen salze des n'n- diacetylcystins
NO20003145D0 (no)	2000-06-16	FremgangsmÕte for fremstilling av paroxetine-hydroklorid
DE59501871D1 (de)	1998-05-20	Monocarbonsäureamide von Polyaminen
DE59500958D1 (de)	1997-12-11	Gliederbrücke
KR960022819U (ko)	1996-07-20	교량의 신축이음장치의 덮개판
KR970002377U (ko)	1997-01-24	조명등용 안정기 고정장치
KR960013117U (ko)	1996-05-17	대다리